These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 324570
1. Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer. Priestman T, Baum M, Jones V, Forbes J. Br Med J; 1977 May 14; 1(6071):1248-50. PubMed ID: 324570 [Abstract] [Full Text] [Related]
2. Management of breast cancer. Cohen IA, Keller JH, Abate MA. Clin Pharm; 1982 May 14; 1(6):515-29. PubMed ID: 6192963 [Abstract] [Full Text] [Related]
3. Combined chemo- and hormonal therapy in advanced breast cancer. Brunner KW, Sonntag RW, Alberto P, Senn HJ, Martz G, Obrecht P, Maurice P. Cancer; 1977 Jun 14; 39(6 Suppl):2923-33. PubMed ID: 326385 [No Abstract] [Full Text] [Related]
4. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial. Heuson JC, Sylvester R, Engelsman E. Eur J Cancer (1965); 1980 Jun 14; Suppl 1():113-7. PubMed ID: 7032920 [No Abstract] [Full Text] [Related]
7. Clinical response to chemotherapy and hormone therapy as first treatment after therapeutic ovariectomy in advanced breast cancer patients. Preda F, Oriana S, Perozziello F, Botte G, Lo Russo V. Tumori; 1982 Apr 30; 68(2):161-5. PubMed ID: 6214880 [Abstract] [Full Text] [Related]
9. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. CMAJ; 1998 Feb 10; 158 Suppl 3():S52-64. PubMed ID: 9484279 [Abstract] [Full Text] [Related]
10. [Prospective randomized trial on the efficacy of adjuvant endocrine therapy for ER-positive breast cancer patients after radical mastectomy]. Jiang Z, Song S, Liu X. Zhonghua Zhong Liu Za Zhi; 2001 Sep 10; 23(5):420-2. PubMed ID: 11810777 [Abstract] [Full Text] [Related]
11. Results of a prospective clinical trial comparing two cytotoxic regimes containing adriamycin in women with advanced breast cancer. Priestman TJ. Clin Oncol; 1975 Sep 10; 1(3):207-11. PubMed ID: 1212828 [No Abstract] [Full Text] [Related]
12. The chemical therapy of breast cancer. Carter SK. Semin Oncol; 1974 Jun 10; 1(2):131-44. PubMed ID: 4220126 [No Abstract] [Full Text] [Related]
15. Treatment and survival on advanced breast cancer. Priestman T, Baum M, Jones V, Forbes J. Br Med J; 1978 Dec 16; 2(6153):1673-4. PubMed ID: 367510 [Abstract] [Full Text] [Related]
16. Mitomycin C in metastatic breast cancer resistant to hormone therapy and conventional chemotherapy. De Lena M, Jirillo A, Brambilla C, Villa S. Tumori; 1980 Aug 31; 66(4):481-87. PubMed ID: 7414712 [Abstract] [Full Text] [Related]
17. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone. Mouridsen HT, Palshof T. Prog Clin Biol Res; 1977 Aug 31; 12():459-66. PubMed ID: 335404 [No Abstract] [Full Text] [Related]
19. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer. Cavalli F, Alberto P, Jungi F, Brunner K, Martz G. Eur J Cancer (1965); 1980 Aug 31; Suppl 1():125-9. PubMed ID: 7032922 [No Abstract] [Full Text] [Related]
20. Studies of the combination of adriamycin and cyclophosphamide (alone or with other agents) for the treatment of breast cancer. Salmon SE, Jones SE. Oncology; 1979 Aug 31; 36(1):40-7. PubMed ID: 156337 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]